Topic 9 — Transfusion Medicine, Blood Safety and Blood-Borne Infections

Connect blood-component therapy, transfusion reactions and blood-borne infection prevention into one rapid-revision pathway.

1. THE TOPIC IN ONE CONNECTED FLOW

Transfusion medicine begins with a safe donor and ends with a safely monitored recipient. Blood is separated into components so the specific deficiency can be corrected. At the same time, every step must prevent incompatible transfusion, transfusion reactions and transmission of important blood-borne pathogens such as HBV, HCV and HIV.

Safe Donor & Collection

Low-risk donor selection + aseptic collection

→

Component Preparation

Whole blood → red cells, platelets, plasma, cryoprecipitate

→

Match Deficiency

Oxygen transport, platelets, coagulation factors or fibrinogen

→

Safety Checks

TTI screening + compatibility + correct patient identification

→

Transfuse & Monitor

Give only indicated component and observe for adverse reactions

→

Possible Harm

Immune reaction, overload, infection or delayed complication

Parallel public-health pathway:

Contaminated blood or unsafe needle exposure
→
HBV / HCV / HIV transmission
→
acute or chronic infection
→
screening, vaccination where available, safe injections and sharps precautions
→
reduced transmission.

2. KEY CLINICAL CONNECTIONS

Component Selection

Symptomatic anemia
→
reduced oxygen-carrying capacity
→
packed red cells

Bleeding + severe thrombocytopenia
→
defective primary hemostasis
→
platelet transfusion

Pulmonary Reaction Distinction

Hypoxemia + pulmonary edema without volume overload
→
increased pulmonary permeability
→
TRALI

Dyspnea + evidence of excess circulatory volume
→
raised hydrostatic pressure
→
TACO

Needle-Stick Exposure

Contaminated sharp injury
→
direct blood exposure
→
HBV / HCV / HIV risk assessment

Prompt washing + reporting
→
timely post-exposure assessment
→
reduced occupational harm

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Specific deficiency → specific component: reduced red-cell mass → packed red cells; platelet deficiency → platelets; multiple coagulation-factor deficiency → fresh frozen plasma; severe fibrinogen deficiency → cryoprecipitate.

ABO incompatibility → recipient antibody and complement activation → intravascular hemolysis → fever, hypotension, hemoglobinuria and possible acute kidney injury or DIC.

⭐ TRALI and TACO both cause post-transfusion respiratory distress → TRALI reflects pulmonary endothelial permeability injury, whereas TACO reflects excessive circulatory volume.

High fever + severe rigors + hypotension during transfusion → consider bacterial contamination → stop transfusion and investigate rather than assuming a simple febrile reaction.

⭐ HBV, HCV and HIV are major blood-borne viral hazards → donor screening and safe injection practices interrupt transmission; HBV additionally has effective vaccine prevention.

Pakistan’s high HCV burden + unsafe parenteral exposure → greater public-health importance of sterile injections, safe transfusion and infection-control practices.

⭐ Safe transfusion is a chain: donor selection → aseptic collection → infection screening → compatibility → storage → patient identification → monitoring; failure at one step can harm the recipient.

Needle-stick prevention → avoid recapping + immediate sharps disposal + HBV vaccination → fewer occupational blood exposures and lower risk of blood-borne infection.

AIM Exam Trap:
Fresh frozen plasma replaces multiple coagulation factors, whereas cryoprecipitate is mainly selected when fibrinogen replacement is required.

Topic 9 — Transfusion Medicine, Blood Safety and Blood-Borne Infections

1. THE TOPIC IN ONE CONNECTED FLOW

2. KEY CLINICAL CONNECTIONS

3. AIM HIGH-YIELD INTEGRATION REVIEW

Install AIM App